Cite

MLA Citation

    Fiona Williams et al.. “Six versus three-weekly pembrolizumab: as well-tolerated?.” Lung cancer, vol. 156, n.d., pp. S11–S12. http://access.bl.uk/ark:/81055/vdc_100131050792.0x00004d
  
Back to record